Selected article for: "broad spectrum and electronic health record"

Author: Shweta, FNU; Murugadoss, Karthik; Awasthi, Samir; Venkatakrishnan, AJ; Puranik, Arjun; Kang, Martin; Pickering, Brian W.; O'Horo, John C.; Bauer, Philippe R.; Razonable, Raymund R.; Vergidis, Paschalis; Temesgen, Zelalem; Rizza, Stacey; Mahmood, Maryam; Wilson, Walter R.; Challener, Douglas; Anand, Praveen; Liebers, Matt; Doctor, Zainab; Silvert, Eli; Solomon, Hugo; Wagner, Tyler; Gores, Gregory J.; Williams, Amy W.; Halamka, John; Soundararajan, Venky; Badley, Andrew D.
Title: Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis
  • Cord-id: n0vi617l
  • Document date: 2020_4_17
  • ID: n0vi617l
    Snippet: Understanding the temporal dynamics of COVID-19 patient phenotypes is necessary to derive fine-grained resolution of pathophysiology. Here we use state-of-the-art deep neural networks over an institution-wide machine intelligence platform for the augmented curation of 15.8 million clinical notes from 30,494 patients subjected to COVID-19 PCR diagnostic testing. By contrasting the Electronic Health Record (EHR)-derived clinical phenotypes of COVID-19-positive (COVIDpos, n=635) versus COVID-19-neg
    Document: Understanding the temporal dynamics of COVID-19 patient phenotypes is necessary to derive fine-grained resolution of pathophysiology. Here we use state-of-the-art deep neural networks over an institution-wide machine intelligence platform for the augmented curation of 15.8 million clinical notes from 30,494 patients subjected to COVID-19 PCR diagnostic testing. By contrasting the Electronic Health Record (EHR)-derived clinical phenotypes of COVID-19-positive (COVIDpos, n=635) versus COVID-19-negative (COVIDneg, n=29,859) patients over each day of the week preceding the PCR testing date, we identify anosmia/dysgeusia (37.4-fold), myalgia/arthralgia (2.6-fold), diarrhea (2.2-fold), fever/chills (2.1-fold), respiratory difficulty (1.9-fold), and cough (1.8-fold) as significantly amplified in COVIDpos over COVIDneg patients. The specific combination of cough and diarrhea has a 3.2-fold amplification in COVIDpos patients during the week prior to PCR testing, and along with anosmia/dysgeusia, constitutes the earliest EHR-derived signature of COVID-19 (4-7 days prior to typical PCR testing date). This study introduces an Augmented Intelligence platform for the real-time synthesis of institutional knowledge captured in EHRs. The platform holds tremendous potential for scaling up curation throughput, with minimal need for retraining underlying neural networks, thus promising EHR-powered early diagnosis for a broad spectrum of diseases.

    Search related documents:
    Co phrase search for related documents
    • academic medical center and active monitoring: 1
    • academic medical center and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • academic medical center and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • academic medical center and acute respiratory disease syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • academic medical center and lung injury: 1
    • academic medical center and machine learning: 1, 2, 3, 4, 5, 6, 7, 8
    • access program and acute ards respiratory distress syndrome: 1
    • access program and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • access program and lung injury: 1, 2
    • account apply and acute respiratory: 1
    • account apply and lung injury: 1
    • ace expression and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • ace expression and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace expression and acute respiratory disease syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • ace expression and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acinar cell and acute respiratory: 1
    • active monitoring and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • active monitoring and acute respiratory disease syndrome: 1, 2, 3, 4
    • active monitoring and lopinavir ritonavir: 1, 2